Usefulness of 123I-BMIPP with myocardial imaging for evaluation of the efficacy of drug therapy in patients with chronic heart failure

Journal of Cardiac Failure

Volumn 7, Issue 3, 2001, Pages 257-264

  Watanabe, Kouki ^a   Sekiya, Michihito ^b   Tsuruoka, Takashi ^c   Funada, Jun Ichi ^b   Miyagawa, Masao ^b  

^a Uwajima City Hospital   (Japan)

^b National Hospital Organization Ehime Medical Center   (Japan)

^c Minamiuwa Ehime Prefectural Hospital   (Japan)

Author keywords

123I Methyl iodophenyl pentadecanoic acid; Angiotensin converting enzyme inhibitor; Chronic heart failure; Fatty acid metabolism

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FATTY ACID;

ADULT; AEROBIC CAPACITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DRUG EFFICACY; ENERGY; FATTY ACID METABOLISM; FEMALE; FLOW RATE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART SCINTISCANNING; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034820053     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1054/jcaf.2001.26313     Document Type: Article

References (35)

1. The natural history of congestive heart failure: The Framingham study
2. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy
3. Which heart failure patients benefit the most from long-term digoxin therapy?
4. Xamoterol in severe heart failure
5. Effect of oral milrinone on mortality in severe chronic heart failure
6. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
7. Effects of the angiotensin-converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure
8. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction
9. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin converting enzyme inhibition
10. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure
11. Fuels, carbohydrates and lipids
12. New radioiodinated methyl-branched fatty acids for cardiac studies
13. Myocardial accumulation of iodinated β-methyl-branched fatty acid analogue, iodine-125-15-(p-iodo-phenyl)-3-(R, S9 methylpenta-decanoic acid) (BMIPP), in relation to ATP concentration
14. Evaluation of myocardial viability with iodine-123-BMIPP in a canine model
15. 123I-BMIPP myocardial scintigraphy for evaluation left ventricular function in patients with chronic heart failure
16. Recommendation regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
17. Percentage of shortening of the echocardiographic left ventricular dimension. It use in determining ejection fraction and stroke volume
18. Myocardial lipid metabolism in compensated and advanced stages of heart failure - Evaluation by canine pacing model with BMIPP
19. Myocardial imaging with 123I-BMIPP in patients with congestive heart failure
20. Fatty acid metabolism in patients with idiopathic dilated cardiomyopathy: Characteristics and prognostic implications
21. Kinetics of radioiodinated species in subcellular fractions from rat hearts following administration of iodine-123-labelled 15-(p-iodophenyl)-3-(R, S)-methylpentadecanoic acid (123I-BMIPP)
22. Radioiodinated 15-(p-iodophenyl)-3, 3-dimethylpentadecanoic acid: A useful new agent to evaluate myocardial fatty acid uptake
23. Coronary angioplasty: A treatment option for left ventricular remodeling after myocardial infarction?
24. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure
25. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II
26. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors
27. Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy
28. Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy
29. Stimulation of endothelin mRNA and secretion in the rat vascular smooth muscle cells: A novel autocrine function
30. Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: Contribution to alterations of vasomotor tone
31. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart
32. Circulating tumor necrosis factor-α (cachectin) in myocardial infarction
33. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
34. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation
35. Angiotensin convening enzyme inhibitors suppress production of tumor necrosis factor-α in vitro and in vivo